1,574
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Emerging Treatments for COPD: Evidence to Date on Revefenacin

&
Pages 112-119 | Received 01 Sep 2019, Accepted 03 Dec 2019, Published online: 13 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maria Gabriella Matera, Carmela Belardo, Michele Rinaldi, Barbara Rinaldi & Mario Cazzola. (2020) Emerging muscarinic receptor antagonists for the treatment of asthma. Expert Opinion on Emerging Drugs 25:2, pages 123-130.
Read now

Articles from other publishers (2)

Zsolt Cselényi, Aurelija Jucaite, Pär Ewing, Per Stenkrona, Cecilia Kristensson, Peter Johnström, Magnus Schou, Martin Bolin, Christer Halldin, Bengt Larsson, Ken Grime, Ulf G Eriksson & Lars Farde. (2023) Proof of lung muscarinic receptor occupancy by tiotropium: Translational Positron Emission Tomography studies in non-human primates and humans. Frontiers in Nuclear Medicine 2.
Crossref
Baofeng Liu, Shuangjiang Zan & Weishun Luo. (2022) Safety evaluation of revefenacin at the approved dose in patients with chronic obstructive pulmonary disease: A meta-analysis. Heart & Lung 52, pages 52-60.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.